
|Videos|February 2, 2021
Clinical care pathway demonstrates efficacy for patients with overactive bladder
Author(s)Urology Times staff
Chris Du, MD, discusses findings from a study published in Neurourology and Urodynamics.
Advertisement
In this interview, Chris Du, MD, discusses findings from the Neurourology and Urodynamics paper, A retrospective longitudinal evaluation of new overactive bladder patients in an FPMRS urologist practice: Are patients following up and utilizing third‐line therapies?, for which he served as a study author. Du is a urology resident at Stony Brook University, Stony Brook, New York.
More videos:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












